Attman P O, Knight-Gibson C, Tavella M, Samuelsson O, Alaupovic P
Department of Nephrology, University of Göteborg, Sweden.
Miner Electrolyte Metab. 1992;18(2-5):199-202.
The dyslipoproteinemia of chronic renal failure (CRF) was characterized by discrete Apo B-containing lipoprotein particles separated by sequential immunoprecipitation of VLDL, IDL and LDL with antisera to Apo E and Apo C-III. CRF patients before and during dialysis had increased concentrations of Apo B-containing lipoproteins (LP) due to increased levels of triglyceride-rich LP-B:C and LP-B:C:E particles with no significant change in the levels of cholesterol-rich LP-B. Patients on hemodialysis had lower concentrations of LP-B:C and higher concentrations of LP-B:C:E than predialytic patients. The increase of Apo B-containing lipoprotein particles in CRF may contribute to atherosclerotic vascular disease and to glomerulosclerosis and progression of renal insufficiency.
慢性肾衰竭(CRF)的血脂蛋白异常表现为,通过用抗载脂蛋白E(Apo E)和抗载脂蛋白C-III(Apo C-III)血清对极低密度脂蛋白(VLDL)、中间密度脂蛋白(IDL)和低密度脂蛋白(LDL)进行连续免疫沉淀,分离出离散的含载脂蛋白B(Apo B)的脂蛋白颗粒。透析前和透析期间的CRF患者,由于富含甘油三酯的LP-B:C和LP-B:C:E颗粒水平升高,含Apo B的脂蛋白(LP)浓度增加,而富含胆固醇的LP-B水平无显著变化。接受血液透析的患者比透析前患者的LP-B:C浓度更低,LP-B:C:E浓度更高。CRF中含Apo B的脂蛋白颗粒增加可能导致动脉粥样硬化性血管疾病以及肾小球硬化和肾功能不全的进展。